BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qin HD, Shugart YY, Bei JX, Pan QH, Chen L, Feng QS, Chen LZ, Huang W, Liu JJ, Jorgensen TJ, Zeng YX, Jia WH. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011;71:3000-8. [PMID: 21368091 DOI: 10.1158/0008-5472.CAN-10-0469] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Franca MM, Condezo YB, Elzaiat M, Felipe-Medina N, Sánchez-Sáez F, Muñoz S, Sainz-Urruela R, Martín-Hervás MR, García-Valiente R, Sánchez-Martín MA, Astudillo A, Mendez J, Llano E, Veitia RA, Mendonca BB, Pendás AM. A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions. Cell Death Differ 2022;29:2347-61. [PMID: 35624308 DOI: 10.1038/s41418-022-01021-z] [Reference Citation Analysis]
2 Xiao RW, Wang F, Wang TM, Zhang JB, Wu ZY, Deng CM, Liao Y, Zhou T, Yang DW, Dong SQ, Xue WQ, He YQ, Zheng XH, Li XZ, Zhang PF, Zhang SD, Hu YZ, Liu YY, Xia YF, Gao S, Mu JB, Feng L, Jia WH. Rare POLN mutations confer risk for familial nasopharyngeal carcinoma through weakened Epstein-Barr virus lytic replication. EBioMedicine 2022;84:104267. [PMID: 36116213 DOI: 10.1016/j.ebiom.2022.104267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Chen Y, Liao Y, Jia X, Lin H, Miao L, Yuan L, Huang X, Zhou J, Bian J, Zhuo Z. Association of ERCC1 and XPF polymorphisms with pediatric glioma susceptibility. Chin Med J (Engl) 2022. [PMID: 36070459 DOI: 10.1097/CM9.0000000000002126] [Reference Citation Analysis]
4 Qu Y, Feng J, Wang L, Wang H, Liu H, Sun X, Li J, Yu H. Association Between Head and Neck Cancers and Polymorphisms 869T/C, 509C/T, and 915G/C of the Transforming Growth Factor-β1 Gene: A Meta-Analysis of Case-Control Studies. Med Sci Monit 2019;25:8389-402. [PMID: 31698408 DOI: 10.12659/MSM.917506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vilkeviciute A, Kriauciuniene L, Chaleckis R, Deltuva VP, Liutkeviciene R. RAD51B (rs8017304 and rs2588809), TRIB1 (rs6987702, rs4351379, and rs4351376), COL8A1 (rs13095226), and COL10A1 (rs1064583) Gene Variants with Predisposition to Age-Related Macular Degeneration. Dis Markers 2019;2019:5631083. [PMID: 31191752 DOI: 10.1155/2019/5631083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li Lung M, Dai W, Ko JM. Nasopharyngeal Carcinoma. Nasopharyngeal Carcinoma 2019. [DOI: 10.1016/b978-0-12-814936-2.00002-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Xu YF, Li YQ, Liu N, He QM, Tang XR, Wen X, Yang XJ, Sun Y, Ma J, Tang LL. Differential genome-wide profiling of alternative polyadenylation sites in nasopharyngeal carcinoma by high-throughput sequencing. J Biomed Sci 2018;25:74. [PMID: 30352587 DOI: 10.1186/s12929-018-0477-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
8 Xue WQ, He YQ, Liao XY, Li FF, Xu YF, Xu FH, Li XZ, Feng QS, Chen LZ, Cao SM, Liu Q, Zeng YX, Jia WH. Decreased oral Epstein-Barr virus DNA loads in patients with nasopharyngeal carcinoma in Southern China: A case-control and a family-based study. Cancer Med 2018. [PMID: 29905022 DOI: 10.1002/cam4.1597] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
9 Qin H, Yao Y. From Family Study to Population Study: A History of Genetic Mapping for Nasopharyngeal Carcinoma (NPC). Applied Computational Genomics 2018. [DOI: 10.1007/978-981-13-1071-3_7] [Reference Citation Analysis]
10 Lu Y, Huang H, Kang M, Yi M, Yang H, Wu S, Wang R. Combined Ki67 and ERCC1 for prognosis in non-keratinizing nasopharyngeal carcinoma underwent chemoradiotherapy. Oncotarget 2017;8:88552-62. [PMID: 29179456 DOI: 10.18632/oncotarget.19158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Cui Q, Zuo XY, Lian YF, Feng QS, Xia YF, He CY, Chen LZ, Jia WH, Mai HQ, Zeng YX, Bei JX. Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis. Tumour Biol 2016;37:14825-30. [PMID: 27639382 DOI: 10.1007/s13277-016-5300-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hang D, Zhou W, Jia M, Wang L, Zhou J, Yin Y, Ma H, Hu Z, Li N, Shen H. Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women. Cancer Med 2016;5:2596-601. [PMID: 27334422 DOI: 10.1002/cam4.797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
13 Sahu SK, Chakrabarti S, Roy SD, Baishya N, Reddy RR, Suklabaidya S, Kumar A, Mohanty S, Maji S, Suryanwanshi A, Rajasubramaniam S, Asthana M, Panda AK, Singh SP, Ganguly S, Shaw OP, Bichhwalia AK, Sahoo PK, Chattopadhyay NR, Chatterjee K, Kundu CN, Das AK, Kannan R, Zorenpuii, Zomawia E, Sema SA, Singh YI, Ghosh SK, Sharma K, Das BS, Choudhuri T. Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case-control study and meta-analysis. Oncogenesis 2016;5:e225. [PMID: 27159678 DOI: 10.1038/oncsis.2016.31] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wu M, Huang S, Liu D, Peng M, Yang F, Wang X. Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysis. Mol Clin Oncol 2016;4:221-8. [PMID: 26893866 DOI: 10.3892/mco.2015.700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Lung ML, Cheung AK, Ko JM, Lung HL, Cheng Y, Dai W. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma. Chin J Cancer 2014;33:556-68. [PMID: 25367335 DOI: 10.5732/cjc.014.10170] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
16 Bode AM, Dong Z, Wang H. Cancer prevention and control: alarming challenges in China. Natl Sci Rev. 2016;3:117-127. [PMID: 27308066 DOI: 10.1093/nsr/nwv054] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
17 Kap EJ, Seibold P, Richter S, Scherer D, Habermann N, Balavarca Y, Jansen L, Becker N, Pfütze K, Popanda O, Hoffmeister M, Ulrich A, Benner A, Ulrich CM, Burwinkel B, Brenner H, Chang-Claude J. Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer. Pharmacogenomics J 2015;15:505-12. [PMID: 25778469 DOI: 10.1038/tpj.2015.8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
18 Hudnall SD. Epstein–Barr Virus: Epidemiology and Clinical Features of Related Cancer. Viruses and Human Cancer 2014. [DOI: 10.1007/978-1-4939-0870-7_3] [Reference Citation Analysis]
19 Cai K, Wang Y, Zhao X, Bao X. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Tumour Biol 2014;35:1891-7. [PMID: 24114013 DOI: 10.1007/s13277-013-1254-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Rubicz R, Yolken R, Drigalenko E, Carless MA, Dyer TD, Bauman L, Melton PE, Kent JW Jr, Harley JB, Curran JE, Johnson MP, Cole SA, Almasy L, Moses EK, Dhurandhar NV, Kraig E, Blangero J, Leach CT, Göring HH. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet 2013;9:e1003147. [PMID: 23326239 DOI: 10.1371/journal.pgen.1003147] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 7.8] [Reference Citation Analysis]
21 Feng B. Descriptive, Environmental and Genetic Epidemiology of Nasopharyngeal Carcinoma. Advances in Experimental Medicine and Biology 2013. [DOI: 10.1007/978-1-4614-5947-7_3] [Cited by in Crossref: 8] [Article Influence: 0.8] [Reference Citation Analysis]
22 Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol 2012;22:107-16. [PMID: 22300735 DOI: 10.1016/j.semcancer.2012.01.007] [Cited by in Crossref: 136] [Cited by in F6Publishing: 118] [Article Influence: 12.4] [Reference Citation Analysis]
23 Jorgensen TJ, Qin H, Shugart YY. From Family Study to Population Study: A History of Genetic Mapping for Nasopharyngeal Carcinoma (NPC). Applied Computational Genomics 2012. [DOI: 10.1007/978-94-007-5558-1_4] [Reference Citation Analysis]
24 Li MJ, Wang P, Liu X, Lim EL, Wang Z, Yeager M, Wong MP, Sham PC, Chanock SJ, Wang J. GWASdb: a database for human genetic variants identified by genome-wide association studies. Nucleic Acids Res 2012;40:D1047-54. [PMID: 22139925 DOI: 10.1093/nar/gkr1182] [Cited by in Crossref: 152] [Cited by in F6Publishing: 162] [Article Influence: 12.7] [Reference Citation Analysis]